Concepedia

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

Khalid Jazieh, Mohammadhadi Khorrami, Anas M. Saad, Mohamed M. Gad, Amit Gupta, Pradnya D. Patil, Vidya Sankar Viswanathan, Prabhakar Rajiah, Charles Nock, Michael Gilkey,

Journal for ImmunoTherapy of Cancer · 2022 · 54 citations · 30 references

DOIFull text

Open access

Abstract

Tumor radiomics of pretreatment CT images from patients with stage III unresectable NSCLC were prognostic of PFS and OS to CRT followed by durvalumab IO and CRT alone.

References

30

Radiomics: Images Are More than Pictures, They Are Data

Robert J. Gillies, Paul E. Kinahan, Hedvig Hricak · Radiology · 2015 · 7.9K citations

, , +16

Decision Curve Analysis: A Novel Method for Evaluating Prediction Models

Andrew J. Vickers, Elena B. Elkin · Medical Decision Making · 2006 · 5K citations · Full text

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.4K citations · Full text

THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL

Robert Tibshirani · Statistics in Medicine · 1997 · 4.2K citations

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text